EP 2376076 A1 20111019 - ANTITUMOR COMBINATION COMBINING AVE8062 AND DOCETAXEL
Title (en)
ANTITUMOR COMBINATION COMBINING AVE8062 AND DOCETAXEL
Title (de)
ANTITUMORALE KOMBINATION MIT AVE8062 UND DOCETAXEL
Title (fr)
COMBINAISON ANTITUMORALE ASSOCIANT L'AVE8062 ET LE DOCETAXEL
Publication
Application
Priority
- FR 2009052475 W 20091210
- FR 0806979 A 20081212
Abstract (en)
[origin: WO2010067027A1] The invention relates to a sequential antitumor combination of AVE8062, or a salt thereof, and docetaxel, characterized in that AVE8062 is administered to a patient in a dose of 10 to 50 mg/m2, and then, on a different day of the week, preferably after a 24-hour interval, docetaxel is administered in a dose of 50 to 120 mg/m2.
IPC 8 full level
A61K 31/167 (2006.01); A61K 31/337 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR US)
A61K 31/167 (2013.01 - EP KR US); A61K 31/337 (2013.01 - EP KR US); A61P 31/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 2010067027A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2010067027 A1 20100617; AR 074599 A1 20110126; AU 2009326220 A1 20110707; BR PI0923349 A2 20150721; CA 2746475 A1 20100617; CL 2011001316 A1 20111028; CN 102245175 A 20111116; CO 6390037 A2 20120229; CR 20110319 A 20110920; EA 201170803 A1 20111230; EC SP11011112 A 20110729; EP 2376076 A1 20111019; FR 2939665 A1 20100618; FR 2939665 B1 20111007; IL 213458 A0 20110731; JP 2012511554 A 20120524; KR 20110104932 A 20110923; MA 32955 B1 20120102; MX 2011006253 A 20111104; NI 201100114 A 20111213; PA 8853301 A1 20100727; PE 20120125 A1 20120223; SG 172071 A1 20110728; TN 2011000268 A1 20121217; TW 201032798 A 20100916; US 2012004294 A1 20120105; UY 32318 A 20100730; ZA 201104358 B 20120926
DOCDB simple family (application)
FR 2009052475 W 20091210; AR P090104814 A 20091211; AU 2009326220 A 20091210; BR PI0923349 A 20091210; CA 2746475 A 20091210; CL 2011001316 A 20110602; CN 200980149772 A 20091210; CO 11072133 A 20110610; CR 20110319 A 20110608; EA 201170803 A 20091210; EC SP11011112 A 20110607; EP 09802160 A 20091210; FR 0806979 A 20081212; IL 21345811 A 20110609; JP 2011540175 A 20091210; KR 20117013250 A 20091210; MA 34002 A 20110708; MX 2011006253 A 20091210; NI 201100114 A 20110608; PA 8853301 A 20091211; PE 2011001197 A 20091210; SG 2011042348 A 20091210; TN 2011000268 A 20110524; TW 98142340 A 20091210; US 201113153975 A 20110606; UY 32318 A 20091211; ZA 201104358 A 20110610